Codex DNA, Inc. (DNAY) Balance Sheet Annual - Discounting Cash Flows
DNAY
Codex DNA, Inc.
DNAY (NASDAQ)
Period Ending: 2022
12-31
2021
12-31
2020
12-31
Report Filing: 2023-03-22 2022-03-23 2020-12-31
Total Current Assets 55.09 93.18 17.18
Cash and Short Term Investments 43.58 82.81 13.46
Cash & Equivalents 30.42 82.81 13.46
Short Term Investments 13.16 0 0
Receivables 5.85 3.67 1.49
Inventory 2.2 2.37 0.601
Other Current Assets 3.46 4.34 1.62
Total Assets 81.36 116.3 26.86
Total Non-Current Assets 26.27 23.07 9.68
Property, Plant and Equipment 8.52 5.74 3.78
Goodwill and Intangible Assets 16.77 16.73 5.82
Goodwill 14.89 14.33 3.5
Intangible Assets 1.88 2.4 2.33
Long Term Investments 0 0 0
Deferred Tax Assets 0 0 0
Other Long Term Assets 0.981 0.609 0.081
Total Current Liabilities 13.5 9.73 5.62
Accounts Payable 1.29 2.5 1.19
Notes Payable/Short Term Debt 0.637 1.84 2.12
Tax Payables 0 0 0
Deferred Revenue 3.96 0.205 0.606
Other Current Liabilities 7.61 5.19 1.71
Total Liabilities 34.8 25.47 52.32
Total Non-Current Liabilities 21.3 15.74 46.7
Total Long Term Debt 20.79 4.46 6.21
Deferred Tax Liabilities Non-Current 0 0 0
Deferred Revenue Non-Current 0.142 0.15 0.04
Capital Lease Obligations 0 0 0
Other Long Term Liabilities 0.367 11.13 40.45
Total Equity 46.56 90.78 -25.46
Non-Controlling Interest 0 0 0
Total Stockholders' Equity 46.56 90.78 -25.46
Retained Earnings -113.7 -65.27 -26.31
Accumulated Other Earnings -0.003 -116.3 0
Common Stock 0.005 0.005 0.002
Preferred Stock 0 116.3 0
Additional Paid in Capital 160.3 156 0.851
Total Liabilities & Total Equity 81.36 116.3 26.86
Total Liabilities & Shareholders' Equity 81.36 116.3 26.86
Total Investments 13.16 0 0
Total Debt 21.43 6.3 8.33
Net Debt -8.99 -76.51 -5.14
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program